Cite
B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
MLA
Cozma, Diana, et al. “B Cell Activator PAX5 Promotes Lymphomagenesis through Stimulation of B Cell Receptor Signaling.” Journal of Clinical Investigation, vol. 117, no. 9, Sept. 2007, pp. 2602–10. EBSCOhost, https://doi.org/10.1172/JCI30842.
APA
Cozma, D., Yu, D., Hodawadekar, S., Azvolinsky, A., Grande, S., Tobias, J. W., Metzgar, M. H., Paterson, J., Erikson, J., Marafioti, T., Monroe, J. G., Atchison, M. L., & Thomas-Tikhonenko, A. (2007). B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. Journal of Clinical Investigation, 117(9), 2602–2610. https://doi.org/10.1172/JCI30842
Chicago
Cozma, Diana, Duonan Yu, Suchita Hodawadekar, Anna Azvolinsky, Shannon Grande, John W. Tobias, Michele H. Metzgar, et al. 2007. “B Cell Activator PAX5 Promotes Lymphomagenesis through Stimulation of B Cell Receptor Signaling.” Journal of Clinical Investigation 117 (9): 2602–10. doi:10.1172/JCI30842.